Neuronetics Inc
STIM4.665USD
+0.245+5.54%
시장 운영 시간 （ET）시세는 15분 지연됩니다
307.05M시가총액
손실P/E TTM
자세한 내용은 Neuronetics Inc 회사
Neuronetics, Inc. is a medical technology company focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its NeuroStar Advanced Therapy for Mental Health is a non-drug, noninvasive treatment for people suffering from neurohealth conditions. In addition to selling the NeuroStar system and associated treatment sessions to customers, it operates treatment centers across the United States, offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or TMS) and Spravato (esketamine nasal spray) for the treatment of major depressive disorder (MDD) and other mental health disorders. NeuroStar Advanced Therapy is the TMS treatment for MDD in adults. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It provides more than 1.68 million treatments to over 51,000 patients struggling with depression.
회사 정보
종목 코드 STIM
회사 이름Neuronetics Inc
상장일Jun 28, 2018
CEOMr. Keith J. Sullivan
직원 수716
유형Ordinary Share
회계 연도 종료Jun 28
주소3222 Phoenixville Pike
도시MALVERN
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호19355
전화18776007555
웹사이트https://neurostar.com/neuronetics/
종목 코드 STIM
상장일Jun 28, 2018
CEOMr. Keith J. Sullivan
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.02M
+1.50%
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.61M
--
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
578.24K
+6.69%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
327.90K
+10.07%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
178.03K
+20.27%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+27.05%
Mr. W. Andrew Macan
Mr. W. Andrew Macan
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
--
--
Dr. Avinash N. Amin, M.D.
Dr. Avinash N. Amin, M.D.
Director
Director
--
--
Mr. Mark Klausner
Mr. Mark Klausner
Managing Partner
Managing Partner
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.02M
+1.50%
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.61M
--
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
578.24K
+6.69%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
327.90K
+10.07%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
178.03K
+20.27%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Clinic revenue
18.66M
58.35%
Treatment sessions
9.76M
30.53%
NeuroStar Advanced Therapy System
3.01M
9.41%
Other
544.00K
1.70%
지역별USD
이름
수익
비율
United States
31.48M
98.46%
International
492.00K
1.54%
사업별
지역별
사업별USD
이름
수익
비율
Clinic revenue
18.66M
58.35%
Treatment sessions
9.76M
30.53%
NeuroStar Advanced Therapy System
3.01M
9.41%
Other
544.00K
1.70%
주식 보유 통계
마지막 업데이트: Thu, Jul 17
마지막 업데이트: Thu, Jul 17
주주
주주 유형
주주
주주
비율
Madryn Asset Management, LP
36.82%
The Vanguard Group, Inc.
3.50%
Cucuz (Sasha)
3.08%
Sullivan (Keith J)
2.44%
Balyasny Asset Management LP
2.15%
Other
52.00%
주주
주주
비율
Madryn Asset Management, LP
36.82%
The Vanguard Group, Inc.
3.50%
Cucuz (Sasha)
3.08%
Sullivan (Keith J)
2.44%
Balyasny Asset Management LP
2.15%
Other
52.00%
주주 유형
주주
비율
Private Equity
36.82%
Hedge Fund
12.75%
Individual Investor
9.48%
Investment Advisor
7.53%
Investment Advisor/Hedge Fund
3.50%
Research Firm
1.84%
Pension Fund
0.09%
Bank and Trust
0.03%
Other
27.96%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
183
47.01M
71.42%
-4.23M
2025Q1
191
47.19M
71.70%
-4.84M
2024Q4
155
36.70M
70.38%
+11.74M
2024Q3
153
14.58M
47.42%
-9.85M
2024Q2
159
20.22M
66.61%
-5.87M
2024Q1
183
20.38M
68.24%
-3.49M
2023Q4
191
18.37M
63.28%
-7.87M
2023Q3
201
19.69M
68.24%
-8.69M
2023Q2
222
21.10M
73.37%
-11.20M
2023Q1
226
22.33M
78.62%
-9.89M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Madryn Asset Management, LP
24.24M
36.82%
--
--
Mar 24, 2025
The Vanguard Group, Inc.
2.31M
3.5%
+1.02M
+79.97%
Mar 31, 2025
Cucuz (Sasha)
2.02M
3.08%
+30.00K
+1.50%
May 22, 2025
Sullivan (Keith J)
1.61M
2.44%
--
--
Mar 24, 2025
Balyasny Asset Management LP
1.42M
2.15%
-64.72K
-4.37%
Mar 31, 2025
Ikarian Capital LLC
1.10M
1.67%
+1.10M
--
Mar 31, 2025
Masters Capital Management, L.L.C.
1.00M
1.52%
-500.00K
-33.33%
Mar 31, 2025
Manatuck Hill Partners, LLC
920.00K
1.4%
+920.00K
--
Mar 31, 2025
Susquehanna International Group, LLP
761.91K
1.16%
+761.91K
--
Mar 31, 2025
Two Sigma Investments, LP
703.67K
1.07%
+703.67K
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
AdvisorShares Psychedelics ETF
6.11%
Invesco NASDAQ Future Gen 200 ETF
0.4%
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
더 보기
AdvisorShares Psychedelics ETF
비율6.11%
Invesco NASDAQ Future Gen 200 ETF
비율0.4%
iShares Micro-Cap ETF
비율0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.02%
iShares Russell 2000 Growth ETF
비율0.01%
ProShares Hedge Replication ETF
비율0%
Proshares Ultra Russell 2000
비율0%
ProShares UltraPro Russell2000
비율0%
iShares Russell 2000 ETF
비율0%
Global X Russell 2000 ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
